English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Psychiatric governance, völkisch corporatism, and the German Research Institute of Psychiatry in Munich (1912-26). Part 2

MPS-Authors
/persons/resource/persons80319

Engström,  Eric J.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80284

Burgmair,  Wolfgang
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80579

Weber,  Matthias M.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Engström, E. J., Burgmair, W., & Weber, M. M. (2016). Psychiatric governance, völkisch corporatism, and the German Research Institute of Psychiatry in Munich (1912-26). Part 2. HISTORY OF PSYCHIATRY, 27(2), 137-152. doi:10.1177/0957154X16629579.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-9EB1-7
Abstract
This is the second of two articles exploring in depth some of the early organizational strategies that were marshalled in efforts to found and develop the German Research Institute of Psychiatry (Deutsche Forschungsanstalt fur Psychiatrie). The first article analysed the strategies of psychiatric governance - best understood as a form of volkisch corporatism - that mobilized a group of stakeholders in the service of higher bio-political and hygienic ends. This second article examines how post-war imperatives and biopolitical agendas shaped the institute's organization and research. It also explores the financial challenges the institute faced amidst the collapse of the German financial system in the early Weimar Republic, including efforts to recruit financial support from the Rockefeller Foundation and other philanthropists in the USA.